Literature DB >> 24332188

Clinical experience with CorMatrix extracellular matrix in the surgical treatment of mitral valve disease.

Marc W Gerdisch1, Richard J Shea2, Michael D Barron2.   

Abstract

OBJECTIVES: To determine the clinical utility of an acellular bioscaffold as a structural material for mitral valve repair (MVr).
METHODS: This was a retrospective study of patients undergoing partial or subtotal leaflet replacement and/or leaflet extension to treat mitral regurgitation or acute endocarditis and/or reconstruction of atrial-ventricular continuity after annular decalcification. The material used for repair was a bioresorbable extracellular matrix (ECM) material indicated for cardiac tissue repair (CorMatrix Cardiovascular, Inc, Roswell, Ga). After the necessary debridement, the ECM bioscaffold was tailored and sewn to the native mitral valve tissue. Intraoperative photographs and serial, follow-up echocardiograms were used for evaluation.
RESULTS: From September 2008 to February 2013, MVr requiring the addition of patch material was performed in 19 patients. The median echocardiographic follow-up was 10.9 months (range, 4 days to 48 months). One early and 2 late deaths were unrelated to MVr. No perioperative or late strokes occurred. Two patients with a history of cancer, chemotherapy, and radiotherapy experienced failure of the initial MVr, necessitating reintervention. The other MVrs continued to show good valvular function and no calcification on echocardiographic follow-up of 4 days to 48 months.
CONCLUSIONS: The ECM bioscaffold is a satisfactory material for MVr in a variety of surgical situations, including endocarditis. It appears to resist calcification and infection. Additional studies are warranted to determine the long-term durability of repairs made with ECM, and its appropriate use in patients who have previously undergone radiotherapy or chemotherapy.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24332188     DOI: 10.1016/j.jtcvs.2013.10.055

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Efficacy of an Extracellular Matrix in Systemic Loading Conditions in Congenital Heart Surgery.

Authors:  Adeel Ashfaq; Amit Iyengar; Oh Jin Kwon; Mohammad S Soroya; Son Nguyen; Ryan Ou; Brian Reemtsen
Journal:  Pediatr Cardiol       Date:  2017-07-15       Impact factor: 1.655

Review 2.  Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials<sup/>.

Authors:  Jenna L Dziki; Luai Huleihel; Michelle E Scarritt; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-05-19       Impact factor: 3.845

Review 3.  Small intestinal submucosa extracellular matrix (CorMatrix®) in cardiovascular surgery: a systematic review.

Authors:  Zahra Mosala Nezhad; Alain Poncelet; Laurent de Kerchove; Pierre Gianello; Caroline Fervaille; Gebrine El Khoury
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-23

4.  Annular and subvalvular dynamics after extracellular matrix mitral tube graft implantation in pigs.

Authors:  Marcell J Tjørnild; Lisa Carlson Hanse; Søren N Skov; Karen B Poulsen; Mona Sharghbin; Leila L Benhassen; Diana M Røpcke; Sten L Nielsen; J Michael Hasenkam
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-27

5.  Dehiscence and embolization of CorMatrix tricuspid valve replacement in the setting of infective endocarditis: a case report.

Authors:  Anna N Tomdio; Melissa Y Y Moey; Irfan Siddiqui; Assad Movahed
Journal:  Eur Heart J Case Rep       Date:  2018-07-31

Review 6.  Cardiac tissue-derived extracellular matrix scaffolds for myocardial repair: advantages and challenges.

Authors:  Pawan Kc; Yi Hong; Ge Zhang
Journal:  Regen Biomater       Date:  2019-04-22

7.  Novel composite trachea grafts using 3-dimensional printing.

Authors:  Joanna F Weber; Sadiq S Rehmani; Mirza Zain Baig; Robert Lebovics; Wissam Raad; Cliff Connery; Faiz Y Bhora
Journal:  JTCVS Open       Date:  2020-11-18

8.  Human Mesenchymal Stem Cells Reendothelialize Porcine Heart Valve Scaffolds: Novel Perspectives in Heart Valve Tissue Engineering.

Authors:  Paola Lanuti; Francesco Serafini; Laura Pierdomenico; Pasquale Simeone; Giuseppina Bologna; Eva Ercolino; Sara Di Silvestre; Simone Guarnieri; Carlo Canosa; Gianna Gabriella Impicciatore; Stella Chiarini; Francesco Magnacca; Maria Addolorata Mariggiò; Assunta Pandolfi; Marco Marchisio; Gabriele Di Giammarco; Sebastiano Miscia
Journal:  Biores Open Access       Date:  2015-06-01

9.  Pathological Changes of Adult Mitral Valves after Failed CorMatrix ECM Repair.

Authors:  Baidarbhi Chakraborty; He Wang
Journal:  J Clin Transl Pathol       Date:  2021-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.